U.S. drugmakers are shipping antiviral drugs to Chinese health authorities to assess whether the medicines could help contain the explosion of respiratory virus infections sweeping the country. AbbVie Inc. and Johnson & Johnson are among the drugmakers that have begun shipping drugs approved to treat HIV, while Gilead Sciences Inc. is exploring whether it should send an antiviral therapy it is developing.

Source: Wall Street Journal January 27, 2020 23:14 UTC